Shashidhar Divakaruni, MD
Interventional Cardiology · Munster, INNPI 1902936578
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $63,755 of the $96,643 with a category attached, or 66.0%. Johnson & Johnson accounts for 72.5% of it on its own, with 51 other manufacturers making up the rest. Reporting peaked in 2019 at $37,794 and has fallen 93.5% since, to $2,441 in 2025. Among interventional cardiology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 744 payments — averaging $129.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$70K
- Medtronic$5K
- Cardiovascular Systems Inc.$3K
- Boston Scientific$2K
- Philips North America LLC$2K
- Amgen$1K
- plus $12K from 46 others
What the payments were for
- Consulting fees$3080%
- Speaking & faculty fees$63,75566%
- Travel & lodging$7,8688%
- Food & beverage$24,60725%
- Education$780%
- Other$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$66,670
- IGT D Peripheral$1,852
- Performa$1,701
- Peripheral Orbital Atherectomy System$1,619
- Watchman$1,187
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$843
- Cook Medical Filters$664
- Indigo System$362
- Repatha$344
- ENTRESTO$337
- COBALT DR MRI SURESCAN$321
- IN.PACT Admiral$284
- NEXLIZET$275
- NEXLETOL$275
- Penumbra System$271
- GENERAL VASCULAR ACCESS$249
- GENERAL ATHERECTOMY$248
- Da Vinci Surgical System$240
- TURNPIKE$237
- Coronary Orbital Atherectomy System$237
How this compares
$96,643 in reported general payments places this provider in the 95th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 177 | $242,919 |
| EntrestoSacubitril/Valsartan | 161 | $182,439 |
| EliquisApixaban | 101 | $104,875 |
| JardianceEmpagliflozin | 27 | $35,305 |
| FarxigaDapagliflozin Propanediol | 29 | $29,186 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 959 | $20,666 |
| OzempicSemaglutide | 12 | $18,209 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $15,004 |
| Prasugrel Hcl | 90 | $12,205 |
| Carvedilol | 1,127 | $8,207 |
| Amiodarone Hcl | 146 | $6,238 |
| ClopidogrelClopidogrel Bisulfate | 503 | $5,526 |
| Ranolazine ErRanolazine | 56 | $5,037 |
| Metoprolol Succinate | 228 | $4,820 |
| MresviaRsv Vaccine, Pref, Mrna/Pf | 13 | $3,856 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $70,056 | $242,919177 claims |
| NovartisEntresto | $1,229 | $182,439161 claims |
| PfizerEliquis | $227 | $104,875101 claims |
| Boehringer IngelheimJardiance | $280 | $35,30527 claims |
| AstraZenecaFarxiga | $997 | $29,18629 claims |
| Novo NordiskOzempic | $242 | $18,20912 claims |
| GSKTrelegy Ellipta | $29 | $15,00421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 170 interventional cardiology providers in Indiana.
Other interventional cardiology in Munster
- Shadi HalabiMunster$31K
- Jonathan MeyerMunster$22K
- Vinod NamanaMunster$20K
- Tariq HameedMunster$12K
- Asad TorabiMunster$11K
- Samer AbbasEast Chicago$395K
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Muzammil MusaniFort Wayne$184K
- Dean FerreraEast Chicago$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.